Cancer Research UK participates in ICGC
Thursday 14 July 2011
Cancer Research UK is participating in the International Cancer Genome Consortium (ICGC), helping to build the largest ever map of the genomic changes that drive 50 different tumour and/or subtypes types.
ICGC will produce vast amounts of genetic information, and this 'blueprint for cancer' will fuel the search for better, more personalised treatments for the millions of people worldwide who are diagnosed with the disease every year.
Cancer Research UK is leading on a project to map the faults in oesophageal cancer, and jointly leading on a prostate cancer project with the Ontario Institute of Cancer Research and Prostate Cancer Canada.
Understanding the genetic faults that drive these cancers will give clues for new, more targeted ways to treat patients and save more lives.
Recent announcements, news and press releases
- Press Release: Early trip to the GP gives big boost to lung cancer patients (9 Dec 2013)
- News story: New tumour suppressor gene discovered (8 Dec 2013)
- Press Release: New EU legislation would halt research and put lives at risk, warns Cancer Research UK (5 Dec 2013)
- News story: Study highlights varying cancer survival rates across Europe (4 Dec 2013)
- Press Release: Prevent proteins folding and you may stop cancer growing (2 Dec 2013)